These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11672929)

  • 21. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
    Pittman PR; Makuch RS; Mangiafico JA; Cannon TL; Gibbs PH; Peters CJ
    Vaccine; 1996 Mar; 14(4):337-43. PubMed ID: 8744562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.
    Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
    Vaccine; 2010 Apr; 28(18):3143-51. PubMed ID: 20193792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Ferguson JA; Reeves WC; Milby MM; Hardy JL
    Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
    Phillpotts RJ
    Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine.
    Bennett AM; Elvin SJ; Wright AJ; Jones SM; Phillpotts RJ
    Vaccine; 2000 Sep; 19(2-3):337-47. PubMed ID: 10930689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ; Bennett AM; Phillpotts RJ
    J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
    Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
    Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
    Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
    Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.
    Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL
    Vaccine; 2010 Jan; 28(4):1031-40. PubMed ID: 19914193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526.
    Rao V; Hinz ME; Roberts BA; Fine D
    Vaccine; 2004 Jun; 22(20):2667-73. PubMed ID: 15193393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS; Ramsburg HH; Edelman R
    J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.